Israeli and European scientists have uncovered a previously unknown molecular mechanism that helps explain why aging and neurological disease are so often accompanied by sleep disturbances, mood disorders, and cognitive decline -- and, crucially, how those effects may be reversed.
Israeli and Dutch researchers have unveiled a new technique that allows scientists to precisely measure toxic protein clumps associated with Alzheimer's disease -- something that has long been out of reach and could open new paths for studying and eventually diagnosing dementia.
Israeli scientists have uncovered a surprising physical mechanism that may influence the development of Alzheimer's disease, which raises new possibilities for the treatment of neurodegenerative diseases.
Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in the restoration of vision in those suffering from multiple sclerosis (MS) and other neurodegenerative diseases.
A novel gene has been linked by researchers in Berlin and Dusseldorf to the development of Huntington's disease in a brain organoid model. Earlier than previously believed, the gene may play a role in brain disorders.
Health outcomes vary greatly among the approximately 1.5 million Americans who survive a traumatic brain injury each year. Not only can these injuries cause loss of coordination, depression, impulsivity, and difficulties concentrating, but they also increase the risk of getting dementia in
Researchers revealed the function of a little-known junction between cells in the brain, which could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer's disease to glioma, a type of brain cancer.
A protein present in the brains of patients suffering from frontotemporal dementia (FTD) has been identified by an international team of researchers, which includes specialists from Indiana University School of Medicine. This finding opens up a new target for possible treatments for FTD.
With the development of new medications that can target the amyloid-beta plaques in the brain that are an early symptom of Alzheimer's disease, new methods for determining whether memory loss and thinking issues are caused by Alzheimer's disease or another neurodegenerative disease are requi
In many neurodegenerative diseases, aberrant proteins build up and spread throughout the brain over time. But aggregation or propagation—which comes first? Japanese researchers offer some fresh perspectives on the mechanism underlying Parkinson's illness.
In a study published recently in C
Israeli scientists have identified a protein could potentially unlock treatments for neurodegenerative diseases by facilitating nerve cell repair in the peripheral nervous system.
Researchers have identified a further possible origin for the genetic abnormalities that give rise to uncommon diseases like Huntington's disease (HD).